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GRAPHICAL ABSTRACT 
 
 
ABSTRACT 
 
Alternating current electrospinning (ACES) capable to reach multiple times higher specific 
productivities than widely used direct current electrospinning (DCES) was investigated and 
compared with DCES to prepare drug-loaded formulations based on one of the most 
widespread polymeric matrix used for commercialized pharmaceutical solid dispersions, 
hydroxypropylmethylcellulose 2910 (HPMC). In order to improve the insufficient 
spinnability of HPMC (both with ACES and DCES) polyethylene oxide (PEO) as secondary 
polymer with intense ACES activity was introduced into the electrospinning solution. 
Different grades of this polymer used at as low concentrations in the fibers as 0.1% or less 
enabled the production of high quality HPMC-based fibrous mats without altering its 
physicochemical properties remarkably. Increasing concentrations of higher molecular weight 
PEOs led to the thickening of fibers from submicronic diameters to several microns of 
thickness. ACES fibers loaded with the poorly water-soluble model drug spironolactone were 
several times thinner than drug-loaded fibers prepared with DCES in spite of the higher 
feeding rates applied. The amorphous HPMC-based fibers with large surface area enhanced 
the dissolution of spironolactone significantly, the presence of small amounts of PEO did not 
affect the dissolution rate. The presented results confirm the diverse applicability of ACES, a 
novel technique to prepare fibrous drug delivery systems.     
        
 
Keywords: electrospinning; nanofibers; hypromellose; dissolution 
enhancement; polyethylene oxide 
1. INTRODUCTION 
 
As a consequence of the increasing number of poorly water-soluble drugs in the recent 
decades numerous techniques have been developed to improve the dissolution properties, and 
thus, the bioavailability of these substances (Kawabata et al., 2011). Among other physical 
approaches such as nanosuspensions (Müller et al., 2001), crystallization techniques (Fages et 
al., 2004; Rasenack and Müller, 2002) and the use of solubilizers (e.g., surfactants (Lawrence 
and Rees, 2000; Pouton, 1997) and cyclodextrins (Brewster and Loftsson, 2007)), polymer-
based solid dispersions has received a great deal of attention to overcome the hurdle of 
limited solubility (Vasconcelos et al., 2007). Amorphous solid dispersion of a drug in an inert 
water-soluble matrix (most often a polymer) ensure improved dissolution owing to three 
reasons: on the one hand higher solubility of the amorphous drug, on the other hand the well-
soluble hydrophilic carrier used, thirdly an increased surface area can be obtained depending 
on the preparation method (Nagy et al., 2012). Accordingly, several amorphous solid 
dispersion-based products have been reached commercialization in the pharmaceutical market 
(Vaka et al., 2014).   
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Electrospinning (ES) is considered to be the simplest technique to produce ultrafine fibers 
with average diameters of 10 nm to 10 μm from solution or melt (H. Wang et al., 2015) under 
the drawing force of the electrostatic field (Li and Xia, 2004; Reneker et al., 2007). Solvent-
based electrospinning has been found to be an excellent method also for the preparation of 
solid dispersions due to the fast and, thus, very efficient amorphization of the drug enclosed in 
the fibers owing a large surface area (Sebe et al., 2015; Yu et al., 2009). Although various 
modifications have been published in respect to the ES setup related mostly to the spinneret 
(e.g., needleless (Molnár and Nagy, 2016), side-by-side (Yu et al., 2016) or multiaxial 
electrospinning (Illangakoon et al., 2015; X. Wang et al., 2015; Yang et al., 2016; Yu et al., 
2015)), the challenge of increasing the productivity of ES could not have been addressed 
considering the high output of other fiber formation techniques such as melt blowing (Balogh 
et al., 2015b).  Recent efforts for scaling up of ES combine the electrostatic field with another 
fiber formation force such as centrifugal force at low (Lomov and Molnár, 2015) and high 
(Nagy et al., 2015) frequencies, or a blow of air (Balogh et al., 2015c). However, as Pokorny 
and his coworkers have pointed out, replacing the static direct current (DC) high voltage 
source generally used for ES to a dynamic alternating current (AC) high voltage also results 
in a significant increase in productivity (Pokorny et al., 2014). 
Alternating current electrospinning (ACES) provides a fairly different way of fiber 
generation than direct current electrospinning (DCES) which can be summarized as follows: 
 
 Higher throughput rates than DCES. The multiple liquid jets ejected from the 
continuously charged-discharged droplet result in multiple-fold rise (up to 20-fold 
with the same spinneret) in productivities during ACES (Lawson et al., 2016; 
Pokorny et al., 2014).   
 Collectorless operation. The movement of the flying AC electrospun so-called 
nanofibrous plume is not affected by ground potential, rather the electric wind 
surrounding the spinneret, i.e., there is no need for a grounded collector (Fig. 1). 
Assuming fiber production in a closed equipment (the case with pharmaceuticals), 
the collection is much easier if the sticking behavior of the fibers observable during 
DCES can be eliminated on grounded surfaces (i.e., almost every other part except 
the charged spinneret).   
 Yarn production. Yarns are the building blocks of other 3-dimensional high value 
fibrous applications (e.g., tissue engineering, composites, etc.), however, preparing 
them using popular DCES is complicated due to the repulsion among the flying 
fibers (Sun et al., 2014). In contrast, the AC electrospun plume can readily turn into 
twisted yarns without difficult collection (Pokorny et al., 2014). 
 Various influencing factors. Besides the main factors affecting DCES (e.g., polymer 
concentration, electric field strength, etc.), further possibilities arise such as 
variations in frequency and waveform of the AC voltage which can be presumably 
used to modify the ACES process (e.g., in respect of productivity or fiber 
morphology). 
 
In our preceding work we demonstrated that ACES is also capable to produce drug-loaded 
fibrous fabrics based on of three pharmaceutically relevant polymers (Eudragit® E, 
Eudragit® L 100-55 and polyvinylpyrrolidone K90 (Balogh et al., 2015a)). Nevertheless, the 
majority (around 50%) of the amorphous solid dispersion-based pharmaceutical products 
commercially available is based on hydroxypropylmethylcellulose (hypromellose, HPMC) 
(Vo et al., 2013). HPMC is a water-soluble hydrophilic non-ionic cellulose ether generally 
used for controlled release tablets due to the polymeric gel layer formed when contacted with 
aqueous media (Li et al., 2005). The success of HPMC as the matrix of amorphous solid 
dispersions can be attributed to the following reasons: (1) HPMC has a high glass transition 
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temperature around 155°C (HPMC 2910 (Nyamweya and Hoag, 2000)) ensuring appropriate 
physical as well as chemical stability for the drug at storage temperature (Hancock et al., 
1995). (2) The precipitation of the supersaturated drug in the dissolution media can be 
effectively inhibited with the use of HPMC (Brouwers et al., 2009). For instance, addition of 
small amount (5%) of HPMC into a surfactant-based formulation of poorly soluble paclitaxel 
resulted in a 10-fold increase in oral bioavailability in rats due to the precipitation inhibition 
effect (Gao and Morozowich, 2006).  
 Thus, in the work outlined in this paper we attempted to prepare electrospun HPMC-based 
fibers for drug delivery purposes for the first time using ACES, and compare ACES to DCES. 
However, the first results obtained left a lot to be desired due to the unacceptable morphology 
of electrospun HPMC. Therefore, based on our experience with ACES of high molecular 
weight polyethylene oxides (PEOs), compositions of HPMC combined with small amounts of 
PEOs were developed with a focus on increasing the throughput rate of ACES. The 
incorporation of a poorly water-soluble model drug (spironolactone) into the optimized 
HPMC-PEO compositions was then evaluated in respect to the effect of drug loading on fiber 
morphology, the physical state of the drug and in vitro dissolution, respectively.            
 
2. MATERIALS AND METHODS 
 
2.1. Materials 
 
Spironolactone (SPIR) from Sigma-Aldrich (Budapest, Hungary) was used as API. 
Hydroxypropylmethylcellulose 2910 5 mPa·s (HPMC) was obtained from Aqualon, Hercules 
(Zwijndrecht, the Netherlands) where 5 mPa·s denotes the viscosity of the aqueous 2% (w/w) 
gel of HPMC (Li et al., 2005). Different grades of polyethylene oxide (PEO) (Mw=100 kDa 
(100kPEO), 1 MDa (1MPEO), 4 MDa (4MPEO)) were kindly provided by Colorcon 
(Budapest, Hungary). Absolute ethanol and dichloromethane was purchased from Molar 
Chemicals (Budapest, Hungary). 
 
2.2. Direct current electrospinning (DCES) 
 
The direct current solvent-based electrostatic spinner used in the experiments was 
equipped with NT-35 high voltage direct current supply (MA2000; Unitronik Ltd, 
Nagykanizsa, Hungary). The electrical potential applied on the spinneret electrode was 25 kV 
in all cases. A grounded aluminum plate covered with aluminum foil was used as collector. 
The distance of the spinneret and the collector was 20 cm and the experiments were 
performed at room temperature. Solutions of the polymeric excipients and the drug were 
prepared for electrospinning using a magnetic stirrer (600 rpm). The solutions were dosed by 
a SEP-10S Plus type syringe pump (Aitecs, Vilnius, Lithuania) through a needle spinneret (1 
mm ID, 2 mm OD). Dosing rate of 10 mL/h was tested. 
 
2.3. Alternating current electrospinning (ACES) 
 
The alternating current electrospinning experiments were conducted using an FME-24 
voltage transformer (24000 V/100 V ratio) (Transzvill Ltd, Budapest, Hungary) fed by a 0-
230 V variable transformer. The electrical potential applied on the spinneret electrode was 25 
kV (root mean square, RMS) at the frequency of the mains voltage (50 Hz). The sinusoidal 
AC high voltage was controlled by manual feedback using the variable transformer based on 
the measured output signal of a high voltage probe connected to the electrode. The 
preparation of polymer solutions was identical to that of used for DCES. The solutions were 
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dosed by a SEP-10S Plus type syringe pump through the same spinneret applied for DCES. 
Dosing rates of 10 mL/h and 30 mL/h were tested, respectively.  
 
2.4. Scanning electron microscopy (SEM) and fiber diameter analysis 
 
Morphology of the samples was investigated by a JEOL 6380LVa (JEOL, Tokyo, Japan) 
type scanning electron microscope. Each specimen was fixed by conductive double-sided 
carbon adhesive tape and sputter-coated with gold prior to the examination. Applied 
accelerating voltage and working distance were 15-30 kV and 10 mm, respectively. A 
randomized fiber diameter determination method was used based on SEM imaging as 
described in our previous work (Balogh et al., 2015b), n=100 measurements were made on 
each sample.  
 
2.5. Differential Scanning Calorimetry (DSC) 
 
Differential scanning calorimetry measurements were carried out using a Setaram (Calure, 
France) DSC 92 apparatus (sample weight: ~10-15 mg, open aluminium pan, nitrogen flush). 
The temperature program consisted of an isothermal period, which lasted for 1 min at 25°C, 
with subsequent linear heating from 25°C to 260°C at the rate of 10°C/min. Purified indium 
standard was used to calibrate the instrument. 
 
2.6. X-ray powder diffraction (XRPD) 
 
Powder X-ray diffraction patterns were recorded by a PANanalytical X’pert Pro MDP X-
ray diffractometer (Almelo, The Netherlands) using Cu-Kα radiation (1.542 Å) and Ni filter. 
The applied voltage was 40 kV while the current was 30 mA. The untreated materials, a 
physical mixture composition and the fibrous samples were analyzed for angles 2θ between 4° 
and 42°. 
 
2.7. In vitro dissolution measurement 
 
The dissolution studies were performed using a Pharmatest PTWS 600 dissolution tester 
(USP II apparatus (paddle); Hainburg, Germany). Samples equivalent to 25 mg of SPIR were 
added directly in the dissolution vessel containing 900 mL dissolution liquid (pH=6.8 100 
mM phosphate buffer prepared according to USP). Electrospun samples were used for 
dissolution tests as spun. The temperature was maintained at 37±0.5°C and stirred at 100 rpm. 
An on-line coupled Agilent 8453 UV-Vis spectrophotometer (Palo Alto, California) was used 
to measure the concentration of dissolved SPIR at a wavelength of 244 nm. Percentage of 
dissolution was readily calculated according to the calibration curves of SPIR due to the lack 
of absorption peaks of the applied excipients in this range. 
 
3. RESULTS AND DISCUSSION 
 
3.1. AC and DC electrospinning of HPMC and PEOs 
 
The first electrospinning experiments revealed that HPMC alone cannot be considered as a 
good fiber forming polymer as both AC and DC electrospinning produced large HPMC 
particles with a minor thin (around 0.5 μm) fibrous fraction (Fig. 2). See Table 1. for 
experimental conditions of pure HPMC, the concentration of HPMC was based on earlier 
research results (Verreck et al., 2003a). DCES of the HPMC solution yielded somewhat more 
fibers than ACES among many droplets, however, the morphology of the product was still not 
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acceptable. Variations in the composition of the electrospinning solution (i.e., the 
concentration of HPMC in ±50% range) did not result in an improved mat quality. Thus, 
further investigations had to be carried out in order to obtain a fibrous HPMC fabric with 
large surface area enough for fast dissolving pharmaceutical applications. 
 
Besides HPMC, different grades of PEOs were also tested with DCES and ACES. See 
Table 1. for experimental conditions of pure PEOs based on preliminary optimization. DCES 
was found to be capable to produce uniform PEO fibers with diameters around 1 μm 
regardless the molecular weight of the polymer (Fig. 2). In contrast to that, only AC 
electrospun fibers of 100 kDa PEO could be prepared with an average diameter three times of 
that of the DC electrospun 100kPEO fibers. The solution of the higher molecular weight 
PEOs (1 MDa or 4 MDa) instantly turned into multiple long liquid jets from the tip of the 
spinneret at lower dosing rates (10 mL/h) during ACES. Besides that, certain part of the 
solution was also removed from inside the spinneret making the process halting for several 
seconds until the solution was refilled again by the pump. Applying higher ACES dosing rates 
of these high molecular weight PEO solutions resulted in some undesired spattering of the 
liquid without the formation of observable fibrous strands. The uncommon inability for ACES 
fiber formation of 1MPEO and 4MPEO implies that PEO-based solutions are more sensitive 
to the AC voltage compared to DCES at the same effective voltage. 
Nevertheless, the opposite electrospinning behavior of HPMC and PEO (too moderate 
versus too active) might compensate each other in a combined composition, therefore, the 
next step was to experimentally verify that assumption.  
 
3.2. Optimization of HPMC-PEO electrospinning        
 
The combination of the poorly electrospunable HPMC and the over-ACES-active PEO was 
expected to resolve the difficulties experienced during the electrospinning experiments. 
Moreover, new advantages might be gained with an improved HPMC-based electrospinning 
system such as the increased feeding rates available with the ACES process. 
In order to obtain the desired good quality HPMC fibrous mats, systematic tests were 
carried out at fixed HPMC concentration (750 mg in 10 mL 50:50 V/V% ethanol-
dichloromethane solvent mixture). Since the concentrations of the electrospinning solutions of 
pure HPMC and those of 1MPEO and 4MPEO distinctly differ (Table 1.) it was anticipated 
that only small amount of PEO is required to advance the fiber formation of HPMC. Gradual 
increase in PEO content was tested during ACES of HPMC, the feeding rate of ACES was set 
to 30 mL/h. As a rule of thumb, the investigated concentration range of each PEO could be 
decreased by one order of magnitude in the presence of HPMC as the molecular weight of 
selected PEOs increased. While addition of a few percent was required from 100kPEO, only 
~0.1-0.5% of 1MPEO or ~0.03-0.05% 4MPEO was sufficient to observe satisfying HPMC 
fibers. Note that these w/w% values are based on weight of the dissolved pure HPMC which 
was taken as 100%. 
Below a certain PEO concentration no fiber formation occurred, only droplets left the 
spinneret and too high PEO concentrations resulted in visible liquid droplet content included 
in the plume. Thus, an optimum could be determined in all cases where fibers without 
droplets could be collected. As depicted in Figure 3, the increasing concentration of 1MPEO 
and 4MPEO resulted in increasing average ACES fiber diameters of a few microns, while 
fibers containing 100kPEO had diameters around 500 nm regardless the concentration of the 
secondary polymer. The scanning electron microscopic images of all optimum HPMC-PEO 
AC electrospun fibers can be also seen in Figure 3 (marked with letters a, b and c). See Table 
2 for exact optimum compositions. 
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ACES feeding rates above 30 mL/h (e.g., 50 mL/h) also resulted in excellent looking 
fibrous plumes when processing the optimum HPMC-PEO solutions using a needle spinneret, 
however, with an emerging dried droplet (of 20-50 μm diameter size) content. The almost two 
orders of magnitude lower absolute concentration of PEOs in their combined solutions with 
HPMC compared to the corresponding concentration of the pure PEO solutions (Table 1. and 
Table 2.) implies that secondary bonding of HPMC with PEO plays an important role in fiber 
formation. The use of 4MPEO was found to be the most challenging with ACES. If very 
small deviations from the optimum occurred it affected not only the fiber diameter but led to 
larger visible liquid droplets in the flying fibrous plume. 
 
3.3. Effect of drug loading on the morphology of HPMC-based AC and DC electrospun fibers   
 
Spironolactone as poorly water-soluble model drug was incorporated into the optimized 
HPMC-based matrices as AC and DC electrospun fibers, the morphology of those can be seen 
in Figure 4. 
Without PEO secondary polymer the 20% SPIR-loaded DC electrospun product contained 
mostly large droplets (10-50 μm in size), however, the HPMC+40%SPIR composition 
processed with DCES was a more acceptable fibrous mat even if frequent defects such as 
droplets or large beads occured. It can thus be concluded that the drug-loading has an 
improving effect on the quality of the electrospun HPMC-based fibers. That observation also 
explains why other research results present good quality DC electrospun HPMC fibers with 
itraconazole incorporated (Verreck et al., 2003a), presumably itraconazole aids similarly or 
even better the formation of HPMC fibers than SPIR. 
AC electrospinning was used to prepare HPMC-PEO-SPIR fibers based on the optimized 
compositions and exploiting the elevated feeding rates available. Excellent morphology of the 
HPMC-PEO ACES SPIR-loaded fibers was achievable regardless the applied higher 
throughput rate. However, as an interesting side effect the reduction in average fiber diameter 
could be observed during ACES along with increasing SPIR loading. Our former experience 
with DC electrospun SPIR-loaded fibers showed that addition of the drug at relatively low 
ratio (≤20%) led to detectable thickening compared to the placebo nonionic Soluplus® fibers 
(Nagy et al., 2012). In order to explore the observed diameter reducing effect of ACES, the 
SPIR-loaded optimized HPMC-PEO fibers were also prepared with DCES applying a 
necessarily lower feeding rate (10 mL/h) and the same voltage as during ACES (25 kV DC).  
The results of the fiber diameter evaluation of AC and DC electrospun HPMC-PEO fibers 
are shown in Figure 5. As it can be seen, DC electrospun fibers had larger average diameters 
in all cases regardless the molecular weight of the PEO or the ratio of the incorporated drug. 
This way the different effect of drug loading on the diameter of AC and DC electrospun fibers 
was confirmed. When 1MPEO or 4MPEO was used as secondary polymer, the DC 
electrospun SPIR-loaded fibers were several microns in thickness, while the average 
diameters of AC electrospun fibers with the same composition approached the submicronic 
region. In turn, using 100kPEO led to no significant thinning in the case of ACES regardless 
the drug loading (fibers were around 500 nm) and only negligible thickening (from 650 nm to 
850 nm) could be detected without SPIR or with 40% SPIR incorporated into DC electrospun 
HPMC-100kPEO fibers.  
It is worth to mention that the observed phenomenon described above may occur only 
when an ionic interaction is not present between the drug and the polymer or the solvent, 
respectively (which is the case with the HPMC-PEO-SPIR system). The experimental results 
with DC electrospinning of aqueous poly(vinyl alcohol) solutions revealed that the presence 
of drug has a thickening effect on the fiber diameter only if the drug was less ionizable 
(Taepaiboon et al., 2006). Furthermore, our recent results with ACES showed that 
electrospinning of a solution containing a weak base drug and an anionic polymer led to 4-6 
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times thicker fibers than the placebo electrospun polymer regardless the type of voltage (AC 
or DC) (Balogh et al., 2015a). The main reason of the different AC and DC electrospinning 
behavior of the same HPMC-PEO-SPIR solutions may lie in the different viscoelastic 
properties of the polymer liquid when an oscillating (ACES) or a constant (DCES) shear force 
is applied, therefore, more detailed studies are needed to elucidate the mechanisms of the 
observed effects.    
 
 
3.4. Physical characterization of drug-loaded HPMC-based fibers 
 
Physical state of SPIR in the HPMC-based fibrous solid dispersions was investigated using 
differential scanning calorimetry (DSC) and X-ray powder diffraction (XRPD) to determine 
the degree of crystallinity of the incorporated drug (Fig. 6). Both AC and DC electrospinning 
can be considered as a very effective tool to produce amorphous solid dispersions (solid 
solutions), however, the solubility advantage during dissolution can be exploited only if there 
are no crystalline traces of the drug in the formulation (Szabó et al., 2015). 
The DSC thermogram of SPIR shows the melting peak of the crystalline structure at 
213°C, while the melting of different grades of semi-crystalline PEOs occurs at regressively 
increasing temperatures as a function of molecular weight (65-70°C). In the case of a 
HPMC+5%SPIR physical mixture reference, besides the wide water loss below 100°C 
belonging to the hydrophilic HPMC polymer the melting of the crystalline drug could be also 
clearly detected. In contrast, the weak glass transition of HPMC was barely observable, the 
literature value for the glass transition temperature of HPMC 2910 is around 155°C 
(Nyamweya and Hoag, 2000). Accordingly, the lack of the crystalline SPIR related melting 
peak at around 210°C implies that both AC and DC electrospinning converted the drug into 
an amorphous form. Even if the DCES process of HPMC+SPIR compositions yielded 
products with imperfect quality (Fig. 4), the low feeding rate and highly volatile organic 
solvents allowed quick drying of the larger particles, and thus, amorphyzation of SPIR. A 
very low portion was used from the secondary polymer PEO in the HPMC-PEO-SPIR 
dispersions, however, the high enthalpy of fusion of PEOs might enable the detection of 
crystalline traces. Despite that, no endothermic peak could be measured at the melting point 
of different PEOs presumably due to their well-mixed state in the HPMC matrix.     
Similarly to DSC, XRPD was also found to be very sensitive to the presence of crystalline 
structures. Crystalline SPIR as well as PEOs with different molecular weight displayed a 
series of characteristic sharp diffraction peaks when examined with XRPD. In the case of the 
physical mixture of HPMC+5%SPIR, the most intense peaks of SPIR were still observable 
and a weak sign of organized structure of HPMC also emerged at 2Θ=32° which latter was 
confirmed by earlier studies as well (Verreck et al., 2003b). Bearing in mind all these and 
considering that SPIR is a poor glass former meaning that it rather tends to crystallize or 
remain crystalline than form amorphous clusters (Nagy et al., 2012), the absence of any X-ray 
diffraction phenomenon or endothermic melting peaks signifies a mixed amorphous form of 
all components including SPIR in the HPMC-based solid dispersions. 
 
3.5. In vitro dissolution of drug-loaded HPMC-based fibers 
 
The results of in vitro dissolution testing of the SPIR-loaded HPMC-based AC and DC 
electrospun fibers are presented in Fig. 7.  
As it can be seen, crystalline SPIR dissolved very slowly, two hours were needed to exceed 
50% dissolution. The electrospun fibers exhibited a significantly improved dissolution due to 
the large surface area and the increased solubility of the amorphous form of SPIR evidenced 
by DSC and XRPD. Theoretically, fibers with higher loadings of a poorly water-soluble drug 
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dissolve slower due to the hydrophobization effect of the drug on the hydrophilic carrier (Van 
Drooge et al., 2006). Despite that, HPMC-PEO+40%SPIR AC electrospun fibers dissolved 
almost two times faster than those of with 20% SPIR content. The reason behind that is the 
propensity of HPMC to form gels instead of dissolving. That way a fibrous structure quickly 
merges when contacted with water losing the large surface area, however, this phenomenon is 
hampered if the dispersion is more hydrophobic. Another peculiar behavior is that the 
HPMC+20%SPIR DCES product consisting mostly large droplets (Fig. 4) dissolved similarly 
than the good quality HPMC-PEO+20%SPIR ACES fibers. The HPMC+40%SPIR DCES 
fibers with a somewhat improved fibrous morphology dissolved noticeably slower than the 
AC electrospun HPMC-PEO fibers with the same fraction of SPIR. Although PEOs are 
known to have limited water solubility due to the very high molecular weights, using them as 
secondary polymers in low concentrations - similarly to the multiple times higher feeding 
rates of ACES - did not have notable effect on the dissolution characteristics. Overall, these 
observations suggest that the main determining factor of dissolution rate in the presented case 
is the ratio of the main ingredients, i.e., HPMC and SPIR but not PEO. Furthermore, other 
effects such as the diffusion of the active species out of the fibers may also occurred 
positively influencing the release rate (Russo and Lamberti, 2011). Higher specific surface 
area (Table 2.) became significant only if the aforementioned gelling is sufficiently 
suppressed like in the case of samples with 40% SPIR. However, the differences in specific 
surface area hardly affected the dissolution speed of those 40%SPIR AC electrospun fibers.  
 
4. CONCLUSIONS 
 
Being one of the mostly used polymers for commercialized amorphous solid dispersion 
products, HPMC 2910 was processed with AC as well as DC electrospinning to improve the 
dissolution of a poorly water-soluble model drug, spironolactone. The insufficient 
morphology of electrospun HPMC was resolved by incorporating small amounts of PEO as 
secondary polymer overly sensitive to ACES. The use of lower grades of PEO such as 100 
kDa and 1 MDa yielded good quality HPMC-based fibers. When PEO with molecular weight 
of 4 MDa was applied the fiber formation was more sensitive to small variations in secondary 
polymer concentration. No traces of crystallinity could be detected in the prepared fibers 
when conducting DSC and XRPD measurements, presumably SPIR and PEO turned into an 
amorphous form as a result of processing. Accordingly, the dissolution of SPIR could be 
greatly enhanced regardless the use of PEOs due to the large surface area, the hydrophilic 
HPMC carrier and the amorphous SPIR content of the fibers.      
The main benefit of alternating current electrospinning, i.e., the multiple times higher 
feeding rates compared to regular direct current electrospinning, was also attainable during 
the production of HPMC-based fibers without remarkable deviations in morphology and 
physical state of the incorporated drug. Besides elevated feeding rates, an unexpected effect of 
alternating current electrospinning was observed: increasing fraction of SPIR resulted in 
thinner fibers as opposed to DCES of the same solutions. The exploration of alternating 
current electrospinning may be an important milestone on the way towards the industrial 
production of electrospun amorphous pharmaceutical solids, however, more detailed studies 
are still required to elucidate the mechanisms affecting ACES fiber formation.  
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Figure 1. The nanofibrous plume generated during alternating current electrospinning without using a 
grounded collector (normal photographic image). 
 
 
 
 
 
Figure 2. Scanning electron microscopic images of AC and DC electrospun hydroxypropylmethylcellulose 
2910 (HPMC) and different grades of polyethylene oxides (100 kDa (100kPEO), 1 MDa (1MPEO), 4 MDa 
(4MPEO)). 
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Figure 3. Average fiber diameters of AC electrospun HPMC-based fibers as a function of amount of 
added PEO with different molecular weight (30 mL/h, 25 kVRMS). Letters (a), (b) and (c) mark the 
optimum compositions (see text and Table 2) and also the corresponding scanning electron microscopic 
images for each HPMC-PEO combination.    
  
16 
 
 
 
Figure 4. Scanning electron microscopic images of AC and DC electrospun spironolactone-loaded (SPIR) 
HPMC-based fibers (DCES: 10 mL/h, 25 kV; ACES: 30 mL/h, 25 kVRMS).   
 
 
 
 
Figure 5. Average fiber diameters of different AC and DC electrospun HPMC-PEO fibers as a function of 
the amount of the incorporated drug (spironolactone) (DCES: 10 mL/h, 25 kV; ACES: 30 mL/h, 25 
kVRMS). 
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Figure 6. Differential scanning calorimetry thermograms (DSC) and X-ray powder diffraction patterns 
(XRPD) of (a) crystalline spironolactone (SPIR), (b-d) applied grades of polyethylene oxides (PEO), (e) 
hydroxypropylmethylcellulose 2910 (HPMC), (f) physical mixture of HPMC and 5% SPIR, and (g-n)  AC 
and DC electrospun HPMC-based SPIR-loaded fibers. 
 
 
 
 
 
Figure 7. Dissolution profiles of SPIR from drug-loaded HPMC-based AC and DC electrospun fibers (as 
spun) containing 20% (left) or 40% (right) SPIR. The error bars indicate the standard deviations (n=3). 
[25 mg dose, 900 mL pH=6.8 100 mM phosphate buffer, USP Dissolution Apparatus 2 (paddle), 100 rpm, 
37°C]  
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Table 1. AC and DC electrospinning parameters of hydroxypropylmethylcellulose 2910 (HPMC) and 
different grades of polyethylene oxides (100 kDa (100kPEO), 1 MDa (1MPEO), 4 MDa (4MPEO)). 
Applied voltage and feeding rate were 25 kVRMS and 10 mL/h, respectively. 
Polymer 
Dissolved polymer in 10 mL 
ethanol-dichloromethane (50:50 
V/V%) (mg) 
HPMC 750 
100kPEO 875 
1MPEO 37.5 
4MPEO 10.6 
 
 
Table 2. AC and DC electrospinning parameters and specific surface area of 
hydroxypropylmethylcellulose 2910 (HPMC)-based dispersions without or with optimized amount of 
different grades of polyethylene oxides (100 kDa (100kPEO), 1 MDa (1MPEO), 4 MDa (4MPEO)), and 
spironolactone (SPIR), respectively. Applied voltage was 25 kVRMS in all cases, DCES and ACES feeding 
rates were fixed to 10 and 30 mL/h, respectively.  
Sample 
Dissolved amount in 10 mL ethanol-
dichloromethane (50:50 V/V%) (mg) 
Specific 
surface area 
(m2/g)a HPMC PEO SPIR 
HPMC+4%100kPEO 750 30 0 5,8 
HPMC+0.2%1MPEO 750 1.5 0 1,7 
HPMC+0.03%4MPEO 750 0.23 0 1,2 
HPMC+20%SPIRb 750 0 188 - 
HPMC+40%SPIRb 750 0 500 - 
HPMC-100kPEO+20%SPIR 750 30 195 6,2 
HPMC-100kPEO+40%SPIR 750 30 520 6,0 
HPMC-1MPEO+20%SPIR 750 1.5 188 3,2 
HPMC-1MPEO+40%SPIR 750 1.5 500 3,9 
HPMC-4MPEO+20%SPIR 750 0.23 188 1,9 
HPMC-4MPEO+40%SPIR 750 0.23 500 2,7 
 a Estimated based on SEM images (density of HPMC = 1280 kg/m3) 
 b Only DC electrospun poor quality samples (see Fig 4.) were prepared, specific surface area is 
not calculated 
